81806-45-3

Usage

Uses

Used in Research Studies:
2,6-Dimethyl-D,L-tyrosine is utilized as a research compound for investigating its properties and potential applications in different scientific domains. Its non-natural structure allows researchers to explore its interactions with biological systems and compare its effects with those of natural amino acids, providing valuable insights into the role of amino acid modifications in biological processes.

Downstream Products

• 245538-30-1 Boc-D,L-Dmt(Boc)-OH 
• 80102-92-7 2-tert-butoxycarbonylamino-3-(4-hydroxy-2,6-dimethyl-phenyl)-propionic acid 
• 245538-31-2 Boc-D,L-Tmt(Boc)-OH 

Relevant academic research and scientific papers

N, N - diethyl - carboxylic acid 4 - halomethyl - 3, 5 - dimethyl - phenol ester compound and its preparation method

The invention relates to an N,N-diethyl-formic acid 4-halogenate methyl-3,5-dimethyl-phenol ester compound and a preparing method thereof. The compound is used for synthesis of dimethyl tyrosine. The compound is more effective than compounds involved in t

NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS

The invention relates to a compound of the formula (I): in which k and j are independently 0 or 1, Y is a macrocycle in which the cycle includes 9 to 36 carbon atoms and is functionalised by three amino functions and by a chain for attaching the spacer arm Z via an X bond, Rc is a binding pattern with a receptor of the TNF superfamily, X is a chemical function for binding the Y group to the space arm, and Z is a bi-, tri- or tetra-functional spacer arm.

NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS

The invention concerns a compound of formula (I), wherein Y represents a macrocycle whereof the cycle comprises 9 to 36 atoms, and is functionalized by three amine or COOH functions; Rc represents a group of formula H—Xa—Xb—Xc—Xd—Xe—(Xf)i—, wherein i represents 0 or 1, Xn is in particular selected among lysine, arginine, ornithine residues, Xb is in particular selected among glycine, asparagine, L-proline or D-proline residues, Xc et Xd are in particular selected among tyrosine, phenylalanine or 3-nitrotyrosine residues, Xe et Xf are in particular selected among the following amino acid residues: NH2—(CH2)n—COOH, n ranging from 1 to 10 or NH2—(CH2—CH2—O)m—CH2CH2COOH, m ranging from 3 to 6, provided that one at least of the amino acid residues Xa, Xb, Xc and Xd is different from the corresponding amino acid in the sequence of the natural CD40 143Lys-Gly-Tyr-Tyr146 fragment

Enkephalin analogs

The invention relates to novel enkephalin analogs of the formula: STR1 which are useful as analgesic agents.

Enkephalin analogs

The invention relates to novel enkephalin analogs of the formula: STR1 which are useful as analgesic agents.